Home|Journals|Articles by Year|Audio Abstracts
 

Case Report

Ann Med Res. 2015; 22(3): 207-209


Medical Therapy in Acute Myocardial Infarction: A Case Report

Abdulmecit Afsin, Julide Yagmur, Mehmet Cansel.




Abstract
Cited by 0 Articles

Acute ST elevation myocardial infarction is among the most important causes of cardiac mortality and morbidity. An 80-year-old female patient was referred to our emergency department with chest pain. The patient, who had been diagnosed with ST elevation inferior and right myocardial infarction, received coronary angiography under primary conditions. There was an intense and long thrombus in the right coronary artery. Therefore, the patient was not considered for percutaneous coronary intervention. Glycoprotein IIb/IIIa receptor blockers and tirofiban were added to antiaggregant and anticoagulant therapy. 2 days later, control coronary angiography did not show any signs of residual thrombus and lesions. Coronary reperfusion was achieved successfully with pharmacological treatment without the requirement of mechanical reperfusion. The patient was discharged without complications with further instructions to regulate the medical treatment. In this paper, we aim to present a case which we successfully treated through pharmacological treatment without the need for an invasive intervention.

Key words: Acute Myocardial Infarction; Thrombus; Tirofiban.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.